<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33562231</PMID><DateCompleted><Year>2021</Year><Month>04</Month><Day>12</Day></DateCompleted><DateRevised><Year>2021</Year><Month>04</Month><Day>12</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>4</Issue><PubDate><Year>2021</Year><Month>Feb</Month><Day>07</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Retinal Ganglion Cell Loss and Microglial Activation in a SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1663</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms22041663</ELocationID><Abstract><AbstractText>The neurodegenerative disease amyotrophic lateral sclerosis (ALS) affects the spinal cord, brain stem, and cerebral cortex. In this pathology, both neurons and glial cells are affected. However, few studies have analyzed retinal microglia in ALS models. In this study, we quantified the signs of microglial activation and the number of retinal ganglion cells (RGCs) in an SOD1G93A transgenic mouse model at 120 days (advanced stage of the disease) in retinal whole-mounts. For SOD1G93A animals (compared to the wild-type), we found, in microglial cells, (i) a significant increase in the area occupied by each microglial cell in the total area of the retina; (ii) a significant increase in the arbor area in the outer plexiform layer (OPL) inferior sector; (iii) the presence of cells with retracted processes; (iv) areas of cell groupings in some sectors; (v) no significant increase in the number of microglial cells; (vi) the expression of IFN-&#x3b3; and IL-1&#x3b2;; and (vii) the non-expression of IL-10 and arginase-I. For the RGCs, we found a decrease in their number. In conclusion, in the SOD1G93A model (at 120 days), retinal microglial activation occurred, taking a pro-inflammatory phenotype M1, which affected the OPL and inner retinal layers and could be related to RGC loss.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rojas</LastName><ForeName>Pilar</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-9137-2261</Identifier><AffiliationInfo><Affiliation>Instituto de Investigaciones Oftalmol&#xf3;gicas Ram&#xf3;n Castroviejo, Universidad Complutense de Madrid, 28040 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto Oft&#xe1;lmico de Madrid, Hospital General Universitario Gregorio Mara&#xf1;&#xf3;n, 28007 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ram&#xed;rez</LastName><ForeName>Ana I</ForeName><Initials>AI</Initials><Identifier Source="ORCID">0000-0002-2656-4723</Identifier><AffiliationInfo><Affiliation>Instituto de Investigaciones Oftalmol&#xf3;gicas Ram&#xf3;n Castroviejo, Universidad Complutense de Madrid, 28040 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>OFTARED-ISCIII, IIORC, Universidad Complutense de Madrid, 28011 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departamento de Inmunolog&#xed;a, Oftalmolog&#xed;a y ORL, Facultad de &#xd3;ptica y Optometr&#xed;a, Universidad Complutense de Madrid, 28037 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cadena</LastName><ForeName>Manuel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Instituto Oft&#xe1;lmico de Madrid, Hospital General Universitario Gregorio Mara&#xf1;&#xf3;n, 28007 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fern&#xe1;ndez-Albarral</LastName><ForeName>Jos&#xe9; A</ForeName><Initials>JA</Initials><Identifier Source="ORCID">0000-0003-0399-7996</Identifier><AffiliationInfo><Affiliation>Instituto de Investigaciones Oftalmol&#xf3;gicas Ram&#xf3;n Castroviejo, Universidad Complutense de Madrid, 28040 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salobrar-Garc&#xed;a</LastName><ForeName>Elena</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-5939-5551</Identifier><AffiliationInfo><Affiliation>Instituto de Investigaciones Oftalmol&#xf3;gicas Ram&#xf3;n Castroviejo, Universidad Complutense de Madrid, 28040 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>OFTARED-ISCIII, IIORC, Universidad Complutense de Madrid, 28011 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departamento de Inmunolog&#xed;a, Oftalmolog&#xed;a y ORL, Facultad de &#xd3;ptica y Optometr&#xed;a, Universidad Complutense de Madrid, 28037 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf3;pez-Cuenca</LastName><ForeName>In&#xe9;s</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0003-0511-515X</Identifier><AffiliationInfo><Affiliation>Instituto de Investigaciones Oftalmol&#xf3;gicas Ram&#xf3;n Castroviejo, Universidad Complutense de Madrid, 28040 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santos-Garc&#xed;a</LastName><ForeName>Irene</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Departamento de Bioqu&#xed;mica y Biolog&#xed;a Molecular, Facultad de Medicina, Instituto Universitario de Investigaci&#xf3;n en Neuroqu&#xed;mica, Universidad Complutense de Madrid, 28011 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto Ram&#xf3;n y Cajal de Investigaci&#xf3;n Sanitaria (IRYCIS), 28040 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Lago</LastName><ForeName>Eva</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-6260-3777</Identifier><AffiliationInfo><Affiliation>Departamento de Bioqu&#xed;mica y Biolog&#xed;a Molecular, Facultad de Medicina, Instituto Universitario de Investigaci&#xf3;n en Neuroqu&#xed;mica, Universidad Complutense de Madrid, 28011 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto Ram&#xf3;n y Cajal de Investigaci&#xf3;n Sanitaria (IRYCIS), 28040 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Urcelay-Segura</LastName><ForeName>Jos&#xe9; L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Instituto Oft&#xe1;lmico de Madrid, Hospital General Universitario Gregorio Mara&#xf1;&#xf3;n, 28007 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departamento de Inmunolog&#xed;a, Oftalmolog&#xed;a y ORL, Facultad de Medicina, Universidad Complutense de Madrid, 28040 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ram&#xed;rez</LastName><ForeName>Jos&#xe9; M</ForeName><Initials>JM</Initials><Identifier Source="ORCID">0000-0002-5145-5094</Identifier><AffiliationInfo><Affiliation>Instituto de Investigaciones Oftalmol&#xf3;gicas Ram&#xf3;n Castroviejo, Universidad Complutense de Madrid, 28040 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>OFTARED-ISCIII, IIORC, Universidad Complutense de Madrid, 28011 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departamento de Inmunolog&#xed;a, Oftalmolog&#xed;a y ORL, Facultad de Medicina, Universidad Complutense de Madrid, 28040 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Hoz</LastName><ForeName>Rosa</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-1581-087X</Identifier><AffiliationInfo><Affiliation>Instituto de Investigaciones Oftalmol&#xf3;gicas Ram&#xf3;n Castroviejo, Universidad Complutense de Madrid, 28040 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>OFTARED-ISCIII, IIORC, Universidad Complutense de Madrid, 28011 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departamento de Inmunolog&#xed;a, Oftalmolog&#xed;a y ORL, Facultad de &#xd3;ptica y Optometr&#xed;a, Universidad Complutense de Madrid, 28037 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salazar</LastName><ForeName>Juan J</ForeName><Initials>JJ</Initials><Identifier Source="ORCID">0000-0001-5480-5902</Identifier><AffiliationInfo><Affiliation>Instituto de Investigaciones Oftalmol&#xf3;gicas Ram&#xf3;n Castroviejo, Universidad Complutense de Madrid, 28040 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>OFTARED-ISCIII, IIORC, Universidad Complutense de Madrid, 28011 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departamento de Inmunolog&#xed;a, Oftalmolog&#xed;a y ORL, Facultad de &#xd3;ptica y Optometr&#xed;a, Universidad Complutense de Madrid, 28037 Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>RD16/0008/0005</GrantID><Agency>Instituto de Salud Carlos III</Agency><Country/></Grant><Grant><GrantID>RED2018-102499-T</GrantID><Agency>Ministerio de Ciencia, Innovaci&#xf3;n y Universidades</Agency><Country/></Grant><Grant><GrantID>RTI2018-0988885-B-I00</GrantID><Agency>Ministerio de Ciencia, Innovaci&#xf3;n y Universidades</Agency><Country/></Grant><Grant><GrantID>b2017/BMD-3813</GrantID><Agency>Comunidad de Madrid</Agency><Country/></Grant><Grant><GrantID>FPU17/01023</GrantID><Agency>Ministerio de Ciencia, Innovaci&#xf3;n y Universidades</Agency><Country/></Grant><Grant><GrantID>CT42/18-CT43/18</GrantID><Agency>Universidad Complutense de Madrid</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>02</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="C000606291">Sod1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="Y">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012165" MajorTopicYN="N">Retinal Ganglion Cells</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">SOD1G93A mouse model</Keyword><Keyword MajorTopicYN="N">anti-inflammatory M2 phenotype</Keyword><Keyword MajorTopicYN="N">microglia</Keyword><Keyword MajorTopicYN="N">microglial activation</Keyword><Keyword MajorTopicYN="N">pro-inflammatory M1 phenotype</Keyword><Keyword MajorTopicYN="N">retina</Keyword><Keyword MajorTopicYN="N">retinal ganglion cells</Keyword><Keyword MajorTopicYN="N">retinal whole-mount</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>12</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>2</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>2</Month><Day>10</Day><Hour>1</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33562231</ArticleId><ArticleId IdType="pmc">PMC7915199</ArticleId><ArticleId IdType="doi">10.3390/ijms22041663</ArticleId><ArticleId IdType="pii">ijms22041663</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Carra S., Crippa V., Rusmini P., Boncoraglio A., Minoia M., Giorgetti E., Kampinga H.H., Poletti A. Alteration of protein folding and degradation in motor neuron diseases: Implications and protective functions of small heat shock proteins. Prog. Neurobiol. 2012;97:83&#x2013;100. doi: 10.1016/j.pneurobio.2011.09.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2011.09.009</ArticleId><ArticleId IdType="pubmed">21971574</ArticleId></ArticleIdList></Reference><Reference><Citation>Yedavalli V.S., Patil A., Shah P. Amyotrophic Lateral Sclerosis and its mimics/variants: A comprehensive review. J. Clin. Imaging Sci. 2018;8:53. doi: 10.4103/jcis.JCIS_40_18.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/jcis.JCIS_40_18</ArticleId><ArticleId IdType="pmc">PMC6302559</ArticleId><ArticleId IdType="pubmed">30652056</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarei S., Carr K., Reiley L., Diaz K., Guerra O., Altamirano P.F., Pagani W., Lodin D., Orozco G., Chinea A. A comprehensive review of amyotrophic lateral sclerosis. Surg. Neurol. Int. 2015;6:171. doi: 10.4103/2152-7806.169561.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/2152-7806.169561</ArticleId><ArticleId IdType="pmc">PMC4653353</ArticleId><ArticleId IdType="pubmed">26629397</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowland L.P., Shneider N.A. Amyotrophic lateral sclerosis. N. Engl. J. Med. 2001;344:1688&#x2013;1700. doi: 10.1056/NEJM200105313442207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200105313442207</ArticleId><ArticleId IdType="pubmed">11386269</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan M.C., Vucic S., Cheah B.C., Turner M.R., Eisen A., Hardiman O., Burrell J.R., Zoing M.C. Amyotrophic lateral sclerosis. Lancet. 2011;377:942&#x2013;955. doi: 10.1016/S0140-6736(10)61156-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61156-7</ArticleId><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen M.K., Roberds S.L., Ellerbrock B.R., Fleck T.J., McKinley D.K., Gurney M.E. Disease mechanisms revealed by transcription profiling in SOD1-G93A transgenic mouse spinal cord. Ann. Neurol. 2001;50:730&#x2013;740. doi: 10.1002/ana.1252.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.1252</ArticleId><ArticleId IdType="pubmed">11761470</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne S., Walsh C., Lynch C., Bede P., Elamin M., Kenna K., McLaughlin R., Hardiman O. Rate of familial amyotrophic lateral sclerosis: A systematic review and meta-analysis. J. Neurol. Neurosurg. Psychiatry. 2011;82:623&#x2013;627. doi: 10.1136/jnnp.2010.224501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.224501</ArticleId><ArticleId IdType="pubmed">21047878</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., Deng H.X., et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science. 1994;264:1772&#x2013;1775. doi: 10.1126/science.8209258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Ripps M.E., Huntleyt G.W., Hoft P.R., Morrisontt J.H., Gordont J.W. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Genetics. 1995;92:689&#x2013;693. doi: 10.1073/pnas.92.3.689.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.92.3.689</ArticleId><ArticleId IdType="pmc">PMC42685</ArticleId><ArticleId IdType="pubmed">7846037</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruijn L.I., Becher M.W., Lee M.K., Anderson K.L., Jenkins N.A., Copeland N.G., Sisodia S.S., Rothstein J.D., Borchelt D.R., Price D.L., et al. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron. 1997;18:327&#x2013;338. doi: 10.1016/S0896-6273(00)80272-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(00)80272-X</ArticleId><ArticleId IdType="pubmed">9052802</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu A.Y., Zhai P., Dal Canto M.C., Peters T.M., Kwon Y.W., Prattis S.M., Gurney M.E. Age-dependent penetrance of disease in a transgenic mouse model of familial amyotrophic lateral sclerosis. Mol. Cell. Neurosci. 1995;6:349&#x2013;362. doi: 10.1006/mcne.1995.1027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/mcne.1995.1027</ArticleId><ArticleId IdType="pubmed">8846004</ArticleId></ArticleIdList></Reference><Reference><Citation>Mourelatos Z., Gonatas N.K., Stieber A., Gurney M.E., Dal Canto M.C. The Golgi apparatus of spinal cord motor neurons in transgenic mice expressing mutant Cu, Zn superoxide dismutase becomes fragmented in early, preclinical stages of the disease. Proc. Natl. Acad. Sci. USA. 1996;93:5472&#x2013;5477. doi: 10.1073/pnas.93.11.5472.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.93.11.5472</ArticleId><ArticleId IdType="pmc">PMC39270</ArticleId><ArticleId IdType="pubmed">8643599</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramirez A.I., de Hoz R., Salobrar-Garc&#xed;a E., Salazar J.J., Rojas B., Ajoy D., L&#xf3;pez-Cuenca I., Rojas P., Trivi&#xf1;o A., Ram&#xed;rez J.M. The role of microglia in retinal neurodegeneration: Alzheimer&#x2019;s disease, Parkinson, and glaucoma. Front. Aging Neurosci. 2017;9:214. doi: 10.3389/fnagi.2017.00214.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2017.00214</ArticleId><ArticleId IdType="pmc">PMC5498525</ArticleId><ArticleId IdType="pubmed">28729832</ArticleId></ArticleIdList></Reference><Reference><Citation>Ram&#xed;rez A.I., Rojas B., de Hoz R., Salazar J.J., Gallego B., Trivi&#xf1;o A., Ram&#xed;rez J.M. Glaucoma. SM Group Open Access eBooks; Dover, DE, USA: 2015. Microglia, inflammation, and glaucoma; pp. 1&#x2013;16.</Citation></Reference><Reference><Citation>Orihuela R., McPherson C.A., Harry G.J. Microglial M1/M2 polarization and metabolic states. Br. J. Pharmacol. 2016;173:649&#x2013;665. doi: 10.1111/bph.13139.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.13139</ArticleId><ArticleId IdType="pmc">PMC4742299</ArticleId><ArticleId IdType="pubmed">25800044</ArticleId></ArticleIdList></Reference><Reference><Citation>Philips T., Robberecht W. Neuroinflammation in amyotrophic lateral sclerosis: Role of glial activation in motor neuron disease. Lancet Neurol. 2011;10:253&#x2013;263. doi: 10.1016/S1474-4422(11)70015-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(11)70015-1</ArticleId><ArticleId IdType="pubmed">21349440</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao B., Zhao W., Beers D.R., Henkel J.S., Appel S.H. Transformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS. Exp. Neurol. 2012;237:147&#x2013;152. doi: 10.1016/j.expneurol.2012.06.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2012.06.011</ArticleId><ArticleId IdType="pmc">PMC4126417</ArticleId><ArticleId IdType="pubmed">22735487</ArticleId></ArticleIdList></Reference><Reference><Citation>Vargas M.R., Johnson J.A. Astrogliosis in Amyotrophic Lateral Sclerosis: Role and therapeutic potential of astrocytes. Neurotherapeutics. 2010;7:471&#x2013;481. doi: 10.1016/j.nurt.2010.05.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nurt.2010.05.012</ArticleId><ArticleId IdType="pmc">PMC2967019</ArticleId><ArticleId IdType="pubmed">20880509</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W., Beers D.R., Henkel J.S., Zhang W., Urushitani M., Julien J.P., Appel S.H. Extracellular mutant SOD1 induces microglial-mediated motoneuron injury. Glia. 2010;58:231&#x2013;243. doi: 10.1002/glia.20919.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.20919</ArticleId><ArticleId IdType="pmc">PMC2784168</ArticleId><ArticleId IdType="pubmed">19672969</ArticleId></ArticleIdList></Reference><Reference><Citation>Roth N.M., Saidha S., Zimmermann H., Brandt A.U., Oberwahrenbrock T., Maragakis N.J., Tumani H., Ludolph A.C., Meyer T., Calabresi P.A., et al. Optical coherence tomography does not support optic nerve involvement in amyotrophic lateral sclerosis. Eur. J. Neurol. 2013;20:1170&#x2013;1176. doi: 10.1111/ene.12146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.12146</ArticleId><ArticleId IdType="pubmed">23582075</ArticleId></ArticleIdList></Reference><Reference><Citation>Ringelstein M., Albrecht P., S&#xfc;dmeyer M., Harmel J., M&#xfc;ller A.K., Keser N., Finis D., Ferrea S., Guthoff R., Schnitzler A., et al. Subtle retinal pathology in amyotrophic lateral sclerosis. Ann. Clin. Transl. Neurol. 2014;1:290&#x2013;297. doi: 10.1002/acn3.46.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.46</ArticleId><ArticleId IdType="pmc">PMC4292746</ArticleId><ArticleId IdType="pubmed">25590041</ArticleId></ArticleIdList></Reference><Reference><Citation>Volpe N.J., Simonett J., Fawzi A.A., Siddique T. Opthalmic manifestations of amyotrophic lateral sclerosis (an American Ophthalmological Society thesis) Trans. Am. Ophthalmol Soc. 2015;113:1&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4731009</ArticleId><ArticleId IdType="pubmed">26877563</ArticleId></ArticleIdList></Reference><Reference><Citation>Fawzi A.A., Simonett J.M., Purta P., Moss H.E., Lowry J.L., Deng H.-X., Siddique N., Sufit R., Bigio E.H., Volpe N.J., et al. Clinicopathologic report of ocular involvement in ALS patients with C9orf72 mutation. Amyotroph. Lateral Scler. Frontotemporal Degener. 2014;15:569&#x2013;580. doi: 10.3109/21678421.2014.951941.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.951941</ArticleId><ArticleId IdType="pmc">PMC4327840</ArticleId><ArticleId IdType="pubmed">25319030</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xfc;bers A., M&#xfc;ller H.P., Dreyhaupt J., B&#xf6;hm K., Lauda F., Tumani H., Kassubek J., Ludolph A.C., Pinkhardt E.H. Retinal involvement in amyotrophic lateral sclerosis: A study with optical coherence tomography and diffusion tensor imaging. J. Neural Transm. 2016;123:281&#x2013;287. doi: 10.1007/s00702-015-1483-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-015-1483-4</ArticleId><ArticleId IdType="pubmed">26582428</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonett J.M., Huang R., Siddique N., Farsiu S., Siddique T., Volpe N.J., Fawzi A.A. Macular sub-layer thinning and association with pulmonary function tests in Amyotrophic Lateral Sclerosis. Sci. Rep. 2016:6. doi: 10.1038/srep29187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep29187</ArticleId><ArticleId IdType="pmc">PMC4935870</ArticleId><ArticleId IdType="pubmed">27383525</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas P., de Hoz R., Ram&#xed;rez A.I., Ferreras A., Salobrar-Garcia E., Mu&#xf1;oz-Blanco J.L., Urcelay-Segura J.L., Ramirez J.M. Changes in retinal OCT and their correlations with neurological disability in early ALS patients, a follow-up study. Brain Sci. 2019;9:337. doi: 10.3390/brainsci9120337.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci9120337</ArticleId><ArticleId IdType="pmc">PMC6955774</ArticleId><ArticleId IdType="pubmed">31771268</ArticleId></ArticleIdList></Reference><Reference><Citation>Ringer C., Weihe E., Sch&#xfc;tz B. SOD1 G93A mutant mice develop a neuroinflammation-independent dendropathy in excitatory neuronal subsets of the olfactory bulb and retina. J. Neuropathol. Exp. Neurol. 2017;76:769&#x2013;778. doi: 10.1093/jnen/nlx057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/nlx057</ArticleId><ArticleId IdType="pubmed">28859334</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho K., Yoon D., Yu M., Peachey N.S., Ferreira P.A. Microglial activation in an amyotrophic lateral sclerosis-like model caused by Ranbp2 loss and nucleocytoplasmic transport impairment in retinal ganglion neurons. Cell. Mol. Life Sci. 2019;76:3407&#x2013;3432. doi: 10.1007/s00018-019-03078-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-019-03078-5</ArticleId><ArticleId IdType="pmc">PMC6698218</ArticleId><ArticleId IdType="pubmed">30944974</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward M.E., Chen R., Huang H.Y., Ludwig C., Telpoukhovskaia M., Taubes A., Boudin H., Minami S.S., Reichert M., Albrecht P., et al. Individuals with progranulin haploinsufficiency exhibit features of neuronal ceroid lipofuscinosis. Sci. Transl. Med. 2017:9. doi: 10.1126/scitranslmed.aah5642.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aah5642</ArticleId><ArticleId IdType="pmc">PMC5526610</ArticleId><ArticleId IdType="pubmed">28404863</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinsant S., Mansfield C., Jimenez-Moreno R., Moore V.D.G., Yoshikawa M., Hampton T.G., Prevette D., Caress J., Oppenheim R.W., Milligan C. Characterization of early pathogenesis in the SOD1G93A mouse model of ALS: Part I, background and methods. Brain Behav. 2013;3:335&#x2013;350. doi: 10.1002/brb3.143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.143</ArticleId><ArticleId IdType="pmc">PMC3869677</ArticleId><ArticleId IdType="pubmed">24381807</ArticleId></ArticleIdList></Reference><Reference><Citation>Philips T., Rothstein J.D. Rodent models of amyotrophic lateral sclerosis. Curr. Protoc. Pharmacol. 2015;69:5.67.1&#x2013;5.67.21. doi: 10.1002/0471141755.ph0567s69.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/0471141755.ph0567s69</ArticleId><ArticleId IdType="pmc">PMC4562058</ArticleId><ArticleId IdType="pubmed">26344214</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K., Boillee S., Roberts E.A., Garcia M.L., McAlonis-Downes M., Mikse O.R., Cleveland D.W., Goldstein L.S.B. Mutant SOD1 in cell types other than motor neurons and oligodendrocytes accelerates onset of disease in ALS mice. Proc. Natl. Acad. Sci. USA. 2008;105:7594&#x2013;7599. doi: 10.1073/pnas.0802556105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0802556105</ArticleId><ArticleId IdType="pmc">PMC2396671</ArticleId><ArticleId IdType="pubmed">18492803</ArticleId></ArticleIdList></Reference><Reference><Citation>Appel S.H., Zhao W., Beers D.R., Henkel J.S. The microglial-motoneuron dialogue in ALS. Acta Myol. 2011;30:4&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3185827</ArticleId><ArticleId IdType="pubmed">21842586</ArticleId></ArticleIdList></Reference><Reference><Citation>Lampson L.A., Kushner P.D., Sobel R.A. Strong expression of class II major histocompatibility complex (MHC) antigens in the absence of detectable T cell infiltration in amyotrophic lateral sclerosis (ALS) spinal cord. J. Neuropathol. Exp. Neurol. 1988;47:353.</Citation></Reference><Reference><Citation>Kawamata T., Akiyama H., Yamada T., Mcgeer P.L. Immunologic reactions in Amyotrophic Lateral Sclerosis brain and spinal cord tissue. Am. J. Pathol. 1992;140:691&#x2013;707.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1886170</ArticleId><ArticleId IdType="pubmed">1347673</ArticleId></ArticleIdList></Reference><Reference><Citation>Sargsyan S.A., Monk P.N., Shaw P.J. Microglia as potential contributors to motor neuron injury in amyotrophic lateral sclerosis. Glia. 2005;51:241&#x2013;253. doi: 10.1002/glia.20210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.20210</ArticleId><ArticleId IdType="pubmed">15846792</ArticleId></ArticleIdList></Reference><Reference><Citation>Boill&#xe9; S., Vande Velde C., Cleveland D.W. ALS: A disease of motor neurons and their nonneuronal neighbors. Neuron. 2006;52:39&#x2013;59. doi: 10.1016/j.neuron.2006.09.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2006.09.018</ArticleId><ArticleId IdType="pubmed">17015226</ArticleId></ArticleIdList></Reference><Reference><Citation>King A.E., Dickson T.C., Blizzard C.A., Woodhouse A., Foster S.S., Chung R.S., Vickers J.C. Neuron-glia interactions underlie ALS-like axonal cytoskeletal pathology. Neurobiol. Aging. 2011;32:459&#x2013;469. doi: 10.1016/j.neurobiolaging.2009.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2009.04.004</ArticleId><ArticleId IdType="pubmed">19427060</ArticleId></ArticleIdList></Reference><Reference><Citation>Ince P.G., Shaw P.J., Slade J.Y., Jones C., Hudgson P. Familial amyotrophic lateral sclerosis with a mutation in exon 4 of the Cu/Zn superoxide dismutase gene: Pathological and immunocytochemical changes. Acta Neuropathol. 1996;92:395&#x2013;403. doi: 10.1007/s004010050535.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004010050535</ArticleId><ArticleId IdType="pubmed">8891072</ArticleId></ArticleIdList></Reference><Reference><Citation>Clement A.M., Nguyen M.D., Roberts E.A., Garcia M.L., Boill&#xe9;e S., Rule M., McMahon A.P., Doucette W., Siwek D., Ferrante R.J., et al. Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science. 2003;302:113&#x2013;117. doi: 10.1126/science.1086071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1086071</ArticleId><ArticleId IdType="pubmed">14526083</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon J.N., Lewis C.A.B., Ajami B., Corbel S.Y., Rossi F.M.V., Krieger C. Origin and distribution of bone marrow-derived cells in the central nervous system in a mouse model of amyotrophic lateral sclerosis. Glia. 2006;53:744&#x2013;753. doi: 10.1002/glia.20331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.20331</ArticleId><ArticleId IdType="pubmed">16518833</ArticleId></ArticleIdList></Reference><Reference><Citation>Ringer C., Luisa-Sybille B., Sch&#xe4;fer M.K., Eiden L.E., Weihe E., Sch&#xfc;tz B. PACAP signaling exerts opposing effects on neuroprotection and neuroinflammation during disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Neurobiol. Dis. 2013;54:32&#x2013;42. doi: 10.1016/j.nbd.2013.02.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2013.02.010</ArticleId><ArticleId IdType="pmc">PMC3955759</ArticleId><ArticleId IdType="pubmed">23466699</ArticleId></ArticleIdList></Reference><Reference><Citation>Ringer C., Tune S., Bertoune M.A., Schwarzbach H., Tsujikawa K., Weihe E., Sch&#xfc;tz B. Disruption of calcitonin gene-related peptide signaling accelerates muscle denervation and dampens cytotoxic neuroinflammation in SOD1 mutant mice. Cell. Mol. Life Sci. 2017;74:339&#x2013;358. doi: 10.1007/s00018-016-2337-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-016-2337-4</ArticleId><ArticleId IdType="pubmed">27554772</ArticleId></ArticleIdList></Reference><Reference><Citation>Ringer C., Weihe E., Sch&#xfc;tz B. Pre-symptomatic alterations in subcellular &#x3b2;CGRP distribution in motor neurons precede astrogliosis in ALS mice. Neurobiol. Dis. 2009;35:286&#x2013;295. doi: 10.1016/j.nbd.2009.05.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2009.05.011</ArticleId><ArticleId IdType="pubmed">19465128</ArticleId></ArticleIdList></Reference><Reference><Citation>De Hoz R., Ram&#xed;rez A.I., Gonz&#xe1;lez-Mart&#xed;n R., Ajoy D., Rojas B., Salobrar-Garc&#xed;a E., Valiente-Soriano F.J., Avil&#xe9;s-Trigueros M., Villegas-P&#xe9;rez M.P., Vidal-Sanz M., et al. Bilateral early activation of retinal microglial cells in a mouse model of unilateral laser-induced experimental ocular hypertension. Exp. Eye Res. 2018;171:12&#x2013;29. doi: 10.1016/j.exer.2018.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exer.2018.03.006</ArticleId><ArticleId IdType="pubmed">29526796</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas B., Gallego B.I., Ram&#xed;rez A.I., Salazar J.J., de Hoz R., Valiente-Soriano F.J., Avil&#xe9;s-Trigueros M., Villegas-Perez M.P., Vidal-Sanz M., Trivi&#xf1;o A., et al. Microglia in mouse retina contralateral to experimental glaucoma exhibit multiple signs of activation in all retinal layers. J. Neuroinflamm. 2014;11:133. doi: 10.1186/1742-2094-11-133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-11-133</ArticleId><ArticleId IdType="pmc">PMC4128533</ArticleId><ArticleId IdType="pubmed">25064005</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Albarral J.A., Ram&#xed;rez A.I., de Hoz R., L&#xf3;pez-Villar&#xed;n N., Salobrar-Garc&#xed;a E., L&#xf3;pez-Cuenca I., Licastro E., Inarejos-Garc&#xed;a A.M., Almod&#xf3;var P., Pinazo-Dur&#xe1;n M.D., et al. Neuroprotective and anti-inflammatory effects of a hydrophilic saffron extract in a model of glaucoma. Int. J. Mol. Sci. 2019;20:4110. doi: 10.3390/ijms20174110.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20174110</ArticleId><ArticleId IdType="pmc">PMC6747458</ArticleId><ArticleId IdType="pubmed">31443568</ArticleId></ArticleIdList></Reference><Reference><Citation>Ram&#xed;rez A.I., de Hoz R., Fern&#xe1;ndez-Albarral J.A., Salobrar-Garc&#xed;a E., Rojas B., Valiente-Soriano F.J., Avil&#xe9;s-Trigueros M., Villegas-P&#xe9;rez M.P., Vidal-Sanz M., Trivi&#xf1;o A., et al. Time course of bilateral microglial activation in a mouse model of laser-induced glaucoma. Sci. Rep. 2020;10:4890. doi: 10.1038/s41598-020-61848-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-61848-9</ArticleId><ArticleId IdType="pmc">PMC7078298</ArticleId><ArticleId IdType="pubmed">32184450</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallego B.I., Salazar J.J., de Hoz R., Rojas B., Ram&#xed;rez A.I., Salinas-Navarro M., Ort&#xed;n-Mart&#xed;nez A., Valiente-Soriano F.J., Avil&#xe9;s-Trigueros M., Villegas-Perez M.P., et al. IOP induces upregulation of GFAP and MHC-II and microglia reactivity in mice retina contralateral to experimental glaucoma. J. Neuroinflamm. 2012;9:92. doi: 10.1186/1742-2094-9-92.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-9-92</ArticleId><ArticleId IdType="pmc">PMC3410794</ArticleId><ArticleId IdType="pubmed">22583833</ArticleId></ArticleIdList></Reference><Reference><Citation>Salobrar-Garc&#xed;a E., Rodrigues-Neves A.C., Ram&#xed;rez A.I., de Hoz R., Fern&#xe1;ndez-Albarral J.A., L&#xf3;pez-Cuenca I., Ram&#xed;rez J.M., Ambr&#xf3;sio A.F., Salazar J.J. Microglial Activation in the Retina of a Triple-Transgenic Alzheimer&#x2019;s Disease Mouse Model (3xTg-AD) Int. J. Mol. Sci. 2020;21:816. doi: 10.3390/ijms21030816.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21030816</ArticleId><ArticleId IdType="pmc">PMC7038053</ArticleId><ArticleId IdType="pubmed">32012676</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry V.H. The influence of systemic inflammation on inflammation in the brain: Implications for chronic neurodegenerative disease. Brain. Behav. Immun. 2004;18:407&#x2013;413. doi: 10.1016/j.bbi.2004.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2004.01.004</ArticleId><ArticleId IdType="pubmed">15265532</ArticleId></ArticleIdList></Reference><Reference><Citation>Moisse K., Strong M.J. Innate immunity in amyotrophic lateral sclerosis. Biochim. Biophys. Acta Mol. Basis Dis. 2006;1762:1083&#x2013;1093. doi: 10.1016/j.bbadis.2006.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2006.03.001</ArticleId><ArticleId IdType="pubmed">16624536</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon S., Martinez F.O. Alternative activation of macrophages: Mechanism and functions. Immunity. 2010;32:593&#x2013;604. doi: 10.1016/j.immuni.2010.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2010.05.007</ArticleId><ArticleId IdType="pubmed">20510870</ArticleId></ArticleIdList></Reference><Reference><Citation>Frakes A.E., Ferraiuolo L., Haidet-Phillips A.M., Schmelzer L., Braun L., Miranda C.J., Ladner K.J., Bevan A.K., Foust K.D., Godbout J.P., et al. Microglia induce motor neuron death via the classical NF-&#x3ba;B pathway in amyotrophic lateral sclerosis. Neuron. 2014;81:1009&#x2013;1023. doi: 10.1016/j.neuron.2014.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.01.013</ArticleId><ArticleId IdType="pmc">PMC3978641</ArticleId><ArticleId IdType="pubmed">24607225</ArticleId></ArticleIdList></Reference><Reference><Citation>Meissner F., Molawi K., Zychlinsky A. Mutant superoxide dismutase 1-induced IL-1&#x3b2; accelerates ALS pathogenesis. Proc. Natl. Acad. Sci. USA. 2010;107:13046&#x2013;13050. doi: 10.1073/pnas.1002396107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1002396107</ArticleId><ArticleId IdType="pmc">PMC2919927</ArticleId><ArticleId IdType="pubmed">20616033</ArticleId></ArticleIdList></Reference><Reference><Citation>Munder M. Arginase: An emerging key player in the mammalian immune system: Review. Br. J. Pharmacol. 2009;158:638&#x2013;651. doi: 10.1111/j.1476-5381.2009.00291.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1476-5381.2009.00291.x</ArticleId><ArticleId IdType="pmc">PMC2765586</ArticleId><ArticleId IdType="pubmed">19764983</ArticleId></ArticleIdList></Reference><Reference><Citation>Cherry J.D., Olschowka J.A., O&#x2019;Banion M.K. Neuroinflammation and M2 microglia: The good, the bad, and the inflamed. J. Neuroinflamm. 2014:11. doi: 10.1186/1742-2094-11-98.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-11-98</ArticleId><ArticleId IdType="pmc">PMC4060849</ArticleId><ArticleId IdType="pubmed">24889886</ArticleId></ArticleIdList></Reference><Reference><Citation>Laffer B., Bauer D., Wasmuth S., Busch M., Jalilvand T.V., Thanos S., Meyer zu H&#xf6;rste G., Loser K., Langmann T., Heiligenhaus A., et al. Loss of IL-10 Promotes Differentiation of Microglia to a M1 Phenotype. Front. Cell. Neurosci. 2019:13. doi: 10.3389/fncel.2019.00430.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2019.00430</ArticleId><ArticleId IdType="pmc">PMC6794388</ArticleId><ArticleId IdType="pubmed">31649508</ArticleId></ArticleIdList></Reference><Reference><Citation>Langmann T. Microglia activation in retinal degeneration. J. Leukoc. Biol. 2007;81:1345&#x2013;1351. doi: 10.1189/jlb.0207114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.0207114</ArticleId><ArticleId IdType="pubmed">17405851</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakagawa Y., Chiba K. Role of microglial M1/M2 polarization in relapse and remission of psychiatric disorders and diseases. Pharmaceuticals. 2014;7:1028&#x2013;1048. doi: 10.3390/ph7121028.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph7121028</ArticleId><ArticleId IdType="pmc">PMC4276905</ArticleId><ArticleId IdType="pubmed">25429645</ArticleId></ArticleIdList></Reference><Reference><Citation>Ivashkiv L.B. IFN&#x3b3;: Signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy. Nat. Rev. Immunol. 2018;18:545&#x2013;558. doi: 10.1038/s41577-018-0029-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-018-0029-z</ArticleId><ArticleId IdType="pmc">PMC6340644</ArticleId><ArticleId IdType="pubmed">29921905</ArticleId></ArticleIdList></Reference><Reference><Citation>Shapiro L.A., Perez Z.D., Foresti M.L., Arisi G.M., Ribak C.E. Morphological and ultrastructural features of Iba1-immunolabeled microglial cells in the hippocampal dentate gyrus. Brain Res. 2009;1266:29&#x2013;36. doi: 10.1016/j.brainres.2009.02.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2009.02.031</ArticleId><ArticleId IdType="pmc">PMC2677570</ArticleId><ArticleId IdType="pubmed">19249294</ArticleId></ArticleIdList></Reference><Reference><Citation>Salinas-Navarro M., Alarc&#xf3;n-Mart&#xed;nez L., Valiente-Soriano F.J., Ort&#xed;n-Mart&#xed;nez A., Jim&#xe9;nez-L&#xf3;pez M., Avil&#xe9;s-Trigueros M., Villegas-P&#xe9;rez M.P., de la Villa P., Vidal-Sanz M. Functional and morphological effects of laser-induced ocular hypertension in retinas of adult albino Swiss mice. Mol. Vis. 2009;15:2578&#x2013;2598.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2790482</ArticleId><ArticleId IdType="pubmed">20011633</ArticleId></ArticleIdList></Reference><Reference><Citation>De Gracia P., Gallego B.I., Rojas B., Ram&#xed;rez A.I., de Hoz R., Salazar J.J., Trivi&#xf1;o A., Ram&#xed;rez J.M. Automatic counting of microglial cells in healthy and glaucomatous mouse retinas. PLoS ONE. 2015;10:e0143278. doi: 10.1371/journal.pone.0143278.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0143278</ArticleId><ArticleId IdType="pmc">PMC4651327</ArticleId><ArticleId IdType="pubmed">26580208</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>